NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

NSE Refines Eligibility Assessment Norms for SME Listings

The National Stock Exchange (NSE) has introduced a revised methodology for calculating Free Cash Flow to Equity (FCFE) for companies seeking to list on its SME platform, NSE Emerge. This move aims to refine eligibility assessment norms and provide a more accurate representation of a company's financial health.

Under the revised framework, proceeds from the issuance of capital, including equity shares, preference shares, and securities premium, will now be included in the computation of FCFE. This marks a significant shift from the earlier definition, which excluded such inflows and relied primarily on cash flow from operations, capital expenditure, and net borrowings. The updated definition will apply with immediate effect to all draft red herring prospectuses (DRHPs) filed on NSE Emerge, as per a circular dated April 17.

The revised methodology is expected to provide some flexibility to companies that rely on equity infusions to support growth. However, market participants have expressed concerns that the change may lead to companies with weak operating cash flows getting listed due to improved FCFE optics. To mitigate this risk, the exchange has in place checks and balances to identify and deal with such companies.

Read also: Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More

Key Changes to FCFE Calculation

NSE has issued detailed clarifications on the computation of FCFE, which are outlined below:

Computation ElementRevised Treatment
Proceeds from issuance of capitalIncluded in FCFE calculation
Short-term borrowingsCaptured either in cash flow from operations or cash flow from financing, but not both
Fixed assetsInclude both tangible and intangible assets, such as patents and copyrights
Financial costsOnly interest on borrowings will be considered, while charges such as bank fees, penalties, and statutory dues will be excluded

Additionally, NSE has provided specific guidance for non-banking financial companies (NBFCs), noting that their business model requires a different treatment of borrowings and interest costs. The exchange has also clarified the treatment of hybrid instruments such as convertible preference shares and debentures, which will be classified based on their treatment in restated financial statements.

Read also: FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round

The requirement introduced in September 2024, mandating positive FCFE in at least 2 of the preceding 3 financial years for SME listings, remains unchanged. The revised methodology is expected to provide a more accurate representation of a company's financial health, and NSE has taken steps to ensure that companies are held to the same standards.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.